Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Localization-related Epilepsy”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Not applicableUnknownNCT02207673
What this trial is testing

A New Method for Delineation of Epileptic Brian Tissue During Epilepsy Surgery (The HFO Study)

Who this might be right for
Refractory Localization-related Epilepsy
UMC Utrecht 78
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Very early researchUnknownNCT05886205
What this trial is testing

Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

Who this might be right for
Refractory Focal Epilepsy
Peking Union Medical College Hospital 34
Not applicableWithdrawnNCT02513992
What this trial is testing

Ictal SPECT With Intra-arterial Injection

Who this might be right for
Epilepsy
Universitaire Ziekenhuizen KU Leuven
Testing effectiveness (Phase 2)Study completedNCT00236730
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 178
Not applicableActive Not RecruitingNCT06681480
What this trial is testing

Transcranial Magnetic Stimulation (rTMS) for Refractory Focal Epilepsy

Who this might be right for
Focal EpilepsyTranscranial Magnetis Stimulation
Comenius University 20
Large-scale testing (Phase 3)Study completedNCT00266591
What this trial is testing

The Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Not applicableStudy completedNCT01772654
What this trial is testing

Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy

Who this might be right for
Focal Epilepsy
Mayo Clinic 73
Large-scale testing (Phase 3)Study completedNCT00988156
What this trial is testing

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Who this might be right for
Partial Epilepsy in Children and Adolescents
Bial - Portela C S.A. 304
Not applicableLooking for participantsNCT03644732
What this trial is testing

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

Who this might be right for
Refractory EpilepsyFocal Epilepsy
University Hospital, Grenoble 200
Testing effectiveness (Phase 2)Study completedNCT00236847
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60
Not applicableLooking for participantsNCT07012148
What this trial is testing

Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

Who this might be right for
Focal EpilepsyGeneralized SeizureDrug Refractory Epilepsy
Mayo Clinic 12
Not applicableUnknownNCT03321240
What this trial is testing

Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia

Who this might be right for
Refractory EpilepsyFocal EpilepsyFocal Cortical Dysplasia
University Hospital, Strasbourg, France 240
Testing effectiveness (Phase 2)Study completedNCT00210522
What this trial is testing

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 421
Testing effectiveness (Phase 2)Study completedNCT02170064
What this trial is testing

Pharmacokinetics, Efficacy and Tolerability of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 35
Not applicableStudy completedNCT03533530
What this trial is testing

Clinical Utility of ESI in Presurgical Evaluation of Patients With Epilepsy

Who this might be right for
ElectroencephalographyRefractory EpilepsyBrain Imaging+1 more
Rigshospitalet, Denmark 82
Testing effectiveness (Phase 2)Study completedNCT00141414
What this trial is testing

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Who this might be right for
Epilepsy, Partial
Pfizer 82
Not applicableStudy completedNCT02866240
What this trial is testing

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory Epilepsy
Neuroelectrics Corporation 20
Not applicableLooking for participantsNCT07580183
What this trial is testing

Spatial Scene Recognition Memory in Epilepsy Surgery

Who this might be right for
Focal EpilepsyTemporal Lobe EpilepsyMedically Refractory Epilepsy+9 more
University of California, Davis 620
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Load More Results